National Cheng Kung University Hostipal
Tainan, Taiwan, 701
Location status: Recruiting
NCT Number: NCT06756646
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
Interested in participating?
Request Info30 year–85 year
All sexes
Interventional
Not applicable
Tainan, Taiwan, 701
Location status: Recruiting
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period.
The participants will be provided by educational program about COPD self-care and home-based exercise approach.
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period.
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Oxygen consumption examined by cardiopulmonary exercise test
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Diaphragm capacity examined by diaphragmatic ultrasound
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Functional capacity examined by 6MWT
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Heart Rate Variability examined by autonomic nervous system
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio.
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Maximum respiratory pressure examined by pressure meter
Time frame: Change from baseline (0 week) to follow up (20 weeks)
Quality of life score examined by mMRC Questionnaire.
Time frame: Change from baseline (0 week) to follow up (20 weeks)
COPD Assessment Test (CAT) questionaire
Time frame: Change from baseline (0 week) to follow up (20 weeks)
St George's Respiratory Questionnaire (SGRQ)
Contact information is provided by the study sponsor or research team.
Kun-Ling Tsai, Ph.D.
CONTACT
886-6-2353535 ext. 5078
Yu-Ting Huang, M.S.
CONTACT
886-6-2353535 ext. 5078
National Cheng Kung University
Other
Exploring the Effects of Aerobic Exercise Combined with Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07073950
Chronic Disease, Chronic Obstructive Pulmonary Disease
Ahrensburg, Germany
View Trial DetailsNCT07512687
Chronic Disease, Chronic Obstructive Pulmonary Disease
Buffalo, New York, United States
View Trial DetailsNCT06862206
Chronic Disease, Chronic Obstructive Pulmonary Disease
Anhui, China
View Trial DetailsNCT06390345
Apnea, Body Weight
Boise, Idaho, United States
View Trial Details